Phillip Choi, BS

Articles by Phillip Choi, BS

Assessing the Chiral Switch: Approval and Use of Single-Enantiomer Drugs, 2001 to 2011

ByWalid F. Gellad, MD, MPH,Phillip Choi, BS,Margaret Mizah, PharmD,Chester B. Good, MD, MPH,Aaron S. Kesselheim, MD, JD, MPH

March 14th 2014

From 2001 to 2011, the US Food and Drug Administration approved 9 single-enantiomer drugs with racemic precursors. None showed pre-approval evidence of improved efficacy over the racemic precursor.

Latest Updated Articles

Assessing the Chiral Switch: Approval and Use of Single-Enantiomer Drugs, 2001 to 2011
March 14th 2014

Phillip Choi, BS

Articles by Phillip Choi, BS

Assessing the Chiral Switch: Approval and Use of Single-Enantiomer Drugs, 2001 to 2011

Latest Updated Articles

Trending on AJMC

Plastic in Personal Care Products Tied to Skin Disease and Environmental Pollution, Review Finds

Delgocitinib Coverage Could Save Health Plans $88M Over 3 Years

Three Years on Baricitinib Preserved Hair Regrowth in Severe Alopecia Areata

First FDA-Approved Inhaled Insulin for Kids Arrives With Mounting Data: Kevin Kaiserman, MD

First Clinical Evidence of Gene Editing, Epigenetic Silencing of HBV cccDNA